New Guidelines for Managing CAR T-Cell Acute Toxicities – Medscape
Medscape |
New Guidelines for Managing CAR T-Cell Acute Toxicities
Medscape Chimeric antigen receptor (CAR) T-cell therapy has emerged as a breakthrough in the treatment of leukemia and lymphoma, but it has been associated with unique acute toxicities that are uncommon with other cancer therapies. These toxicities can be fatal … |
